PRKN and Parkinson disease: The results of Celardo et al. [141] demonstrate that in Parkinson's disease models with pink1 and parkin mutations, inhibition of PERK signaling leads to neuroprotective effects by decreasing Mfn interactions with the ER, thereby enhancing ER stress signaling.